EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
EYPT on Nasdaq
Shares outstanding
82,201,196
Price per share
$15.45
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
83,461,964
Total reported value
$1,524,925,802
% of total 13F portfolios
0%
Share change
+13,618,624
Value change
+$260,059,117
Number of holders
162
Price from insider filings
$15.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 10% $99,097,350 8,265,000 Cormorant Asset Management, LP 04 Dec 2025
Adage Capital Management, L.P. 5.7% -30% $81,921,000 -$14,986,000 4,700,000 -15% Adage Capital Management, L.P. 31 Dec 2025
FEDERATED HERMES, INC. 6.7% $43,281,744 4,599,450 Federated Hermes, Inc. 30 Jun 2025
BlackRock, Inc. 6.5% $63,872,124 4,485,402 BlackRock, Inc. 30 Sep 2025
Paradigm Biocapital Advisors LP 5.1% $64,770,432 4,192,261 Paradigm BioCapital Advisors LP 17 Feb 2026
FRANKLIN RESOURCES INC 6.1% -18% $27,059,688 +$820,894 4,137,567 +3.1% Franklin Resources, Inc. 31 Dec 2024
TCG Crossover GP II, LLC 4.3% $62,265,799 3,572,335 TCG Crossover GP II, LLC 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P. 4.7% $20,809,090 3,181,818 RA Capital Management, L.P. 31 Dec 2024

As of 31 Dec 2025, 162 institutional investors reported holding 83,461,964 shares of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT). This represents 102% of the company’s total 82,201,196 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Cormorant Asset Management, LP 10% 8,265,000 -0.72% 8.6% $151,001,550
SUVRETTA CAPITAL MANAGEMENT, LLC 9.5% 7,827,685 +26% 3.6% $143,011,805
BlackRock, Inc. 8.3% 6,787,872 +37% 0% $124,014,422
FEDERATED HERMES, INC. 7.3% 6,017,433 +36% 0.18% $109,938,500
FRANKLIN RESOURCES INC 6.1% 4,976,915 +19% 0.02% $90,928,238
VANGUARD GROUP INC 5.9% 4,822,139 +27% 0% $88,100,480
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.7% 4,700,000 -15% 0.13% $85,869,000
Paradigm Biocapital Advisors LP 4.5% 3,691,475 +84% 1.8% $67,443,248
TCG Crossover Management, LLC 4.3% 3,572,335 0% 2.2% $65,266,560
JANUS HENDERSON GROUP PLC 3.6% 2,937,729 0.02% $53,657,620
ORBIMED ADVISORS LLC 3% 2,468,314 +37% 0.96% $45,096,097
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,899,367 +25% 0% $34,709,656
STATE STREET CORP 2.2% 1,834,850 +25% 0% $33,522,710
Aberdeen Group plc 2% 1,605,984 +102% 0.05% $29,341,328
GOLDMAN SACHS GROUP INC 1.5% 1,249,757 -17% 0% $22,833,061
Parkman Healthcare Partners LLC 1.3% 1,088,033 1.9% $19,878,363
Essex Woodlands Management, Inc. 1.3% 1,084,857 0% 6.2% $19,820,336
5AM Venture Management, LLC 1.3% 1,050,000 0% 6% $19,183,500
Spruce Street Capital LP 1.2% 981,543 0% 5.9% $17,932,791
Alyeska Investment Group, L.P. 0.95% 784,403 +290% 0.04% $14,331,043
Patient Square Capital LP 0.95% 780,000 -23% 3.1% $14,250,600
Artia Global Partners LP 0.93% 767,098 +22% 2.3% $14,014,880
Rosalind Advisors, Inc. 0.84% 690,000 +6.2% 4.8% $12,606,300
Candriam S.C.A. 0.82% 674,395 0.06% $12,321,721
Schonfeld Strategic Advisors LLC 0.8% 661,452 0.06% $12,084,727

Institutional Holders of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 83,461,964 $1,524,925,802 +$260,059,117 $18.27 162
2025 Q3 69,898,687 $995,227,037 +$20,107,476 $14.24 148
2025 Q2 68,912,118 $648,484,078 -$21,934,653 $9.41 139
2025 Q1 74,070,140 $401,203,753 -$6,558,607 $5.42 149
2024 Q4 74,299,852 $553,357,101 +$114,467,368 $7.45 141
2024 Q3 58,498,731 $476,138,776 -$4,424,916 $7.99 135
2024 Q2 58,415,381 $508,206,601 -$17,769,473 $8.70 148
2024 Q1 55,009,467 $1,137,046,639 +$106,318,844 $20.67 161
2023 Q4 49,565,894 $1,145,491,759 +$422,510,894 $23.11 138
2023 Q3 33,709,262 $269,337,991 +$16,845,118 $7.99 98
2023 Q2 31,573,084 $274,685,383 +$22,852,995 $8.70 82
2023 Q1 29,111,970 $85,592,348 -$1,206,242 $2.94 66
2022 Q4 29,377,926 $102,818,972 -$13,441,865 $3.50 72
2022 Q3 30,106,241 $238,140,639 -$883,849 $7.91 82
2022 Q2 30,200,779 $237,683,742 -$3,357,027 $7.87 78
2022 Q1 30,440,222 $369,919,357 +$7,173,181 $12.15 78
2021 Q4 29,839,293 $365,363,130 +$94,551,507 $12.24 83
2021 Q3 22,128,108 $230,547,815 +$14,765,407 $10.42 61
2021 Q2 20,739,059 $186,447,743 +$7,944,014 $8.99 59
2021 Q1 19,642,118 $199,571,620 +$124,369,380 $10.16 58
2020 Q4 7,703,318 $50,684,935 +$50,684,935 $6.58 31